Bloomberg Markets & Finance via Youtube

Aug.24 — Harvard Global Health Institute Director Dr. Ashish Jha says the U.S. Food and Drug Administration’s confirmation that an Emergency Use Authorization was granted for the use of Covid-19 convalescent plasma for the treatment of hospitalized patients doesn’t seem to be grounded in science. He speaks with Bloomberg’s Kaily Leinz and Guy Johnson on “Bloomberg Markets: European Close.”

READ ALSO  SE: 'Luxury Sector Ripe For Consolidation', Says GAM's Ramachandran